Display options
Cite
Babai L, Papp JG, Parratt JR, et al. The antiarrhythmic effects of ischaemic preconditioning in anaesthetized dogs are prevented by atropine; role of changes in baroreceptor reflex sensitivity. Br J Pharmacol. 2002;135(1):55-64doi: 10.1038/sj.bjp.0704445.
Babai, L., Papp, J. G., Parratt, J. R., & Végh, A. (2002). The antiarrhythmic effects of ischaemic preconditioning in anaesthetized dogs are prevented by atropine; role of changes in baroreceptor reflex sensitivity. British journal of pharmacology, 135(1), 55-64. https://doi.org/10.1038/sj.bjp.0704445
Babai, László, et al. "The antiarrhythmic effects of ischaemic preconditioning in anaesthetized dogs are prevented by atropine; role of changes in baroreceptor reflex sensitivity." British journal of pharmacology vol. 135,1 (2002): 55-64. doi: https://doi.org/10.1038/sj.bjp.0704445
Babai L, Papp JG, Parratt JR, Végh A. The antiarrhythmic effects of ischaemic preconditioning in anaesthetized dogs are prevented by atropine; role of changes in baroreceptor reflex sensitivity. Br J Pharmacol. 2002 Jan;135(1):55-64. doi: 10.1038/sj.bjp.0704445. PMID: 11786480; PMCID: PMC1573109.
Copy Download .nbib Format: NLM
Share it on

Br J Pharmacol. 2002 Jan;135(1):55-64. doi: 10.1038/sj.bjp.0704445.

The antiarrhythmic effects of ischaemic preconditioning in anaesthetized dogs are prevented by atropine; role of changes in baroreceptor reflex sensitivity.

British journal of pharmacology

László Babai, Julius Gy Papp, James R Parratt, Agnes Végh

Affiliations

  1. Department of Pharmacology and Pharmacotherapy, University of Szeged, Albert Szent-Györgyi Faculty of Medicine, Dóm tér 12, P.O. Box 427, H-6701 Hungary.

PMID: 11786480 PMCID: PMC1573109 DOI: 10.1038/sj.bjp.0704445

Abstract

1. Dogs, anaesthetized with chloralose and urethane, were subjected to a 25 min occlusion of the left anterior descending coronary artery. This resulted in ventricular ectopic activity, a reduction in baroreflex sensitivity (BRS, measured following the intravenous administration of phenylephrine), elevations in the epicardial ST-segment and increases in the degree of inhomogeneity of electrical activation, both measured from the ischaemic region of the left ventricular wall. 2. These changes were markedly reduced when the 25 min occlusion was preceded, 20 min earlier, by a 5 min (preconditioning) occlusion of the same coronary artery (e.g. VF during ischaemia reduced from 40% in the controls to 0%; P<0.05; BRS increased from 1.22+/-0.23 pre-occlusion to 1.61+/-0.25 mmHg ms(-1) post-occlusion in preconditioned dogs; cf. 1.28+/-0.29 to 0.45+/-0.12 mmHg ms(-1) respectively in the controls, P<0.05). 3. These beneficial effects of preconditioning were prevented by the administration, 10 min prior to the 25 min coronary artery occlusion, of atropine (1 mg kg(-1) i.v. followed by a continuous infusion of 0.04 mg kg(-1) h(-1)). For example, VF during occlusion was increased from 0% in the preconditioned dogs to 40% (P<0.05) in the presence of atropine and BRS was again reduced during occlusion (from 1.75+/-0.29 to 0.30+/-0.08 mmHg ms(-1); P<0.05). 4. We conclude that preconditioning reduces arrhythmia severity during ischaemia by favourably modifying cardiac autonomic receptor mechanism through enhancing vagal influences.

References

  1. Circulation. 1985 Sep;72(3):623-31 - PubMed
  2. J Clin Invest. 1985 Oct;76(4):1592-8 - PubMed
  3. Am J Physiol. 1985 Nov;249(5 Pt 2):H1045-50 - PubMed
  4. Fed Proc. 1986 Jul;45(8):2191-6 - PubMed
  5. Circulation. 1987 Apr;75(4):877-87 - PubMed
  6. Am J Physiol. 1987 Dec;253(6 Pt 2):H1470-6 - PubMed
  7. Circulation. 1988 Apr;77(4):935-46 - PubMed
  8. Microsc Res Tech. 1994 Oct 1;29(2):161-8 - PubMed
  9. Cardiovasc Res. 1994 Nov;28(11):1726-34 - PubMed
  10. Br J Pharmacol. 1994 Dec;113(4):1167-72 - PubMed
  11. Circ Res. 1995 May;76(5):861-70 - PubMed
  12. Am J Cardiol. 1995 May 1;75(14):877-81 - PubMed
  13. Circ Res. 1995 Oct;77(4):841-8 - PubMed
  14. Circ Res. 1996 Apr;78(4):573-80 - PubMed
  15. J Mol Cell Cardiol. 1996 Oct;28(10):2085-95 - PubMed
  16. J Am Coll Cardiol. 1997 Apr;29(5):1035-8 - PubMed
  17. Hypertension. 1997 May;29(5):1119-25 - PubMed
  18. Eur J Pharmacol. 1998 Mar 5;344(2-3):203-13 - PubMed
  19. Cardiovasc Res. 1998 Aug;39(2):373-80 - PubMed
  20. J Am Coll Cardiol. 1998 Nov 15;32(6):1641-7 - PubMed
  21. J Appl Physiol (1985). 1999 Feb;86(2):510-6 - PubMed
  22. Am J Cardiol. 1999 Apr 1;83(7):1000-5 - PubMed
  23. Cardiovasc Res. 1999 Jan;41(1):41-54 - PubMed
  24. Br Med J. 1972 Jul 8;3(5818):89-92 - PubMed
  25. Circ Res. 1973 Feb;32(2):215-20 - PubMed
  26. Circulation. 1973 Jan;47(1):44-50 - PubMed
  27. Acta Physiol Scand. 1973 Dec;89(4):544-9 - PubMed
  28. Circulation. 1974 May;49(5):943-7 - PubMed
  29. Circ Res. 1974 Dec;35(6):896-908 - PubMed
  30. Am J Cardiol. 1976 Jun;37(7):1046-51 - PubMed
  31. Adv Cardiol. 1978;25:119-29 - PubMed
  32. Cardiovasc Res. 1980 May;14(5):303-6 - PubMed
  33. Circ Res. 1981 Aug;49(2):511-8 - PubMed
  34. Ann N Y Acad Sci. 1982;382:162-80 - PubMed
  35. Circulation. 1988 Oct;78(4):816-24 - PubMed
  36. Circulation. 1988 Oct;78(4):969-79 - PubMed
  37. Circ Res. 1989 Mar;64(3):437-48 - PubMed
  38. Am J Physiol. 1989 Dec;257(6 Pt 2):H1886-94 - PubMed
  39. Circ Res. 1991 May;68(5):1471-81 - PubMed
  40. Cardiovasc Res. 1990 Dec;24(12):1020-3 - PubMed
  41. Am J Physiol. 1991 Jul;261(1 Pt 2):H63-9 - PubMed
  42. Circ Res. 1991 Aug;69(2):325-31 - PubMed
  43. Circ Res. 1991 Nov;69(5):1389-401 - PubMed
  44. Br Heart J. 1992 Feb;67(2):129-37 - PubMed
  45. Br J Pharmacol. 1991 Oct;104(2):294-5 - PubMed
  46. Cardiovasc Res. 1991 Dec;25(12):1051-3 - PubMed
  47. Am Heart J. 1992 Oct;124(4):883-90 - PubMed
  48. Cardiovasc Res. 1992 May;26(5):487-95 - PubMed
  49. Br J Pharmacol. 1992 Nov;107(3):648-52 - PubMed
  50. Br J Pharmacol. 1993 Feb;108(2):318-22 - PubMed
  51. Cardiovasc Res. 1993 Apr;27(4):690-1 - PubMed
  52. Am Heart J. 1993 Aug;126(2):347-51 - PubMed
  53. Clin Sci (Lond). 1999 Jul;97(1):5-17 - PubMed
  54. Cardiovasc Res. 1999 Sep;43(4):832-4 - PubMed
  55. J Mol Cell Cardiol. 2000 Mar;32(3):405-14 - PubMed
  56. Am J Physiol Heart Circ Physiol. 2001 Jan;280(1):H216-21 - PubMed
  57. Circ Res. 1969 Jan;24(1):109-21 - PubMed
  58. Circ Res. 1970 Feb;26(2):211-24 - PubMed
  59. Circ Res. 1972 Feb;30(2):158-66 - PubMed
  60. Circ Res. 1993 Oct;73(4):656-70 - PubMed
  61. Circ Res. 1993 Dec;73(6):1193-201 - PubMed
  62. J Am Coll Cardiol. 1993 Nov 1;22(5):1335-7 - PubMed
  63. Trends Pharmacol Sci. 1994 Jan;15(1):19-25 - PubMed
  64. Circulation. 1994 Aug;90(2):1023-8 - PubMed
  65. Circulation. 1982 Oct;66(4):874-80 - PubMed
  66. Circ Res. 1983 May;52(5):597-607 - PubMed
  67. Am Heart J. 1983 Jun;105(6):958-65 - PubMed
  68. J Am Coll Cardiol. 1984 Mar;3(3):760-5 - PubMed
  69. Circulation. 1984 Apr;69(4):790-800 - PubMed
  70. Br Heart J. 1984 Oct;52(4):418-21 - PubMed
  71. Prog Cardiovasc Dis. 1984 Nov-Dec;27(3):201-22 - PubMed

Substances

MeSH terms

Publication Types